▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

Revvity Ignites Scientific Breakthroughs at SLAS2025

Revvity, Inc. is set to unveil its groundbreaking new Phenologic.AI™ software at SLAS2025 in San Diego, January 27-29. Designed to redefine cellular imaging workflows for Revvity’s Harmony™ and ...

Business Wire

Unveils revolutionary solution for cellular imaging, alongside a wide range of solutions for accelerating drug discovery and development

WALTHAM, Mass.: Revvity, Inc. is set to unveil its groundbreaking new Phenologic.AI™ software at SLAS2025 in San Diego, January 27-29. Designed to redefine cellular imaging workflows for Revvity’s Harmony™ and Signals Image Artist™ software packages, the Phenologic.AI software leverages pre-trained deep-learning models to analyze brightfield images, providing an additional multiplexing channel and streamlined workflows for live cell analysis. This significant advancement expands the possibilities for understanding cellular behaviors and disease mechanisms. The Phenologic.AI offering provides scalable, efficient, and objective analysis and can be integrated with Revvity Signals Research Suite™ to provide more in-depth data analytics.

Complementing this launch, Revvity will also introduce other notable products, including the latest Harmony™ 5.3 software, which simplifies data management for high-content imaging and analysis, providing faster and more intuitive data handling.

Attendees can explore these technologies and more at Revvity’s booth (#1318), where over 40 products from its life sciences portfolio will be showcased. These include solutions for assay development, automation, cellular research, liquid handling, flow cytometry, and reagents, all designed to accelerate innovation and efficiency across drug discovery and development. Revvity’s strategy centers on supporting scientists in overcoming research challenges with transformative technologies.

Kevin Quick, vice president of platforms, life sciences, stated, "SLAS is a great opportunity to showcase our most innovative technologies and celebrated brands. Our strategy and offerings are designed to support scientists in accelerating discoveries and expediting progress from basic research into clinical development.”

Key Exhibits at SLAS2025
Revvity’s featured solutions include:

  • Assay Development and Automation: Custom automation solutions to boost throughput and reliability, including the explorer™ G3 integrated workstation.
  • Automated Liquid Handling: The Fontus™ liquid handler offers intuitive software, optimized protocols, and reformatting capabilities for streamlined productivity.
  • Cell Imaging and AI: Advanced tools like the Opera Phenix™ Plus HCS system, alongside the Phenologic.AI offering.
  • Reagents Portfolio: Including PhenoVue™ imaging reagents, BioLegend antibodies, and Dharmacon™ CRISPR screening libraries.

For detailed information on the showcased innovations, scientific talks, and posters, visit booth #1318 or Revvity’s SLAS2025 events page.

For research use only. Not for use in diagnostic procedures.

About Revvity
At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.

With 2023 revenue of more than $2.7 billion and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.

Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

RSA at Cybertech Europe 2024

Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…

Italian Security Awards 2024: G11 Media honours the best of Italian cybersecurity

G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Most read

Synapse ITS Appoints Josh LittleSun as Chief Technology Officer to Drive…

#PressRelease--Synapse ITS (“Synapse”), a leader in transportation safety, is pleased to announce the appointment of Josh LittleSun as its new Chief Technology…

Rocket Lab Launches Next Batch of Satellites for Kinéis Constellation

$RKLB--Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today successfully launched…

ADTRAN Holdings, Inc. to release fourth quarter 2024 financial results…

#Adtran--ADTRAN Holdings, Inc. (NASDAQ: ADTN) announced today that the Company will release its financial results for the fourth quarter 2024 after market…

AO Mainnet Launches, Ushering in a New Era of Decentralized Computing…

AO, a revolutionary platform for decentralized computing, launches its mainnet today following a highly successful testnet phase, with key milestones…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!